Ceradyne Blows Past Estimates

Ceradyne (CRDN) reported earnings today. They were as good as any earnings can get. Yet, the stock barely moved. While previous earnings reports have resulted in wild swings in the stock price, this time around, investors were calm. Volume was high but the stock remained stagnant. They even guided higher. I guess until they show diversity in their product line and reduce their dependence on government contracts, the stock is range bound. That or an analyst upgrade will do the trick. 

– Faisal Laljee